Non-Invasive Prenatal Testing (NIPT) Market: Current Analysis and Forecast (2021-2027)


By Product (Instruments {Ultrasound Devices, Next-Generation Sequencing Systems, Polymerase Chain Reaction Instruments, Microarrays, Others}, Consumables {Assay Kits & Reagents, Disposables}); By Method (Ultrasound Detection, Biochemical Screening Tests, Cell-Free DNA in Maternal Plasma Tests); By Application (Trisomy Detection, Microdeletion Detection, Others); By End-User (Hospitals & Clinics, Diagnostic Laboratories, Others); Regions and Country

Detailed Analysis of COVID-19 Impact on the Non-Invasive Prenatal Testing (NIPT) Market







Report ID:



  Get a Sample
SKU: UMHE21727 Categories: ,
Report Description
Table of content
Research Methodology

Report Description

Non-Invasive Prenatal Testing (NIPT) Market
Non-Invasive Prenatal Testing (NIPT) Market


Non-Invasive Prenatal Testing (NIPT) Market is anticipated display a CAGR of around 14.7% over the forecast period (2021-2027). Mutations in genes and chromosomes can increase the risk of genetic abnormalities in an unborn child. The rising prevalence of chromosomal abnormalities has resulted in a surge in demand for a reliable screening tool for prenatal tests. The high risk of chromosomal abnormalities with increasing maternal age, a growing preference for non-invasive techniques over invasive methods, and an improving reimbursement scenario for NIPT are the crucial factors driving the market growth. Several established players as well as new start-ups are looking for funding to conduct research and clinical testing on NIPT techniques. Many government and private organizations are keenly looking for research institutes and start-ups for the development of innovative testing procedures to detect key genetic disorders through NIPT. For instance, in June 2019, Cradle Genomics, a San-Diego-based start-up, raised over US$ 17 Mn in Series A funding carried out to support clinical development, corporate infrastructure, CLIA lab operations, and commercial launch of the tests.

Insights Presented in the Report

“Amongst Product, Consumables segment held significant market share in 2020”

Based on product, the market is categorized into instruments and consumables. The consumables segment is further segmented into assay kits & reagents and disposables. Assay kits & reagents includes ultrasound transmission gel, cleaning solution etc. The disposables comprises of swipes, cottons, hand gloves, etc. The high demand for consumables attributes to market participants introducing new test kits and the increasing number of lab-based tests performed globally. Furthermore, one of the major factors driving and fueling demand for reagents and consumables is the increasing number of research and development activities for screening genetic disorders. Technological advancements in instruments, as well as increased collaboration among players, are other crucial factors proliferating the global adoption of consumables for the detection of abnormalities during pregnancy.


“Amongst Method, Cell-Free DNA in Maternal Plasma Tests to acquire largest market share”

Based on the method, the market is bifurcated into Ultrasound Detection, Biochemical Screening Tests, and Cell-Free DNA in Maternal Plasma Tests. Of these three, Cell-Free DNA in Maternal Plasma Tests acquires the largest share of the Non-Invasive Prenatal Testing (NIPT) Market. The segment’s rapid growth can be attributed to technological advancements and increased company initiatives to develop new products. Cell-free DNA is increasingly being used in prenatal care to predict the risk of genetic conditions using various genetic analyses. Several research studies are being conducted to advance the use of tests available through this method. For example, Togneri et al. published a study in December 2019 that implemented and validated cell-free DNA-based NIPT in the National Health Service (NHS) regional genetics laboratory. The researchers concluded that cfDNA-based NIPT can be performed as a private test in patients with a low risk of common trisomy or for other reasons.

“North America will Dominate the Market During the Forecast Period”

For a better understanding of the market adoption of Non-Invasive Prenatal Testing (NIPT), the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific), and Rest of World. In 2020, North America region held the highest market share in the global Non-Invasive Prenatal Testing (NIPT) market. Some of the major players operating in the market are Illumina, Inc., Yourgene Health, Natera, F. Hoffmann-La Roche Ltd., PerkinElmer Inc., Laboratory Corporation of America, Eurofins LifeCodexx GmbH, Centogene N.V., Quest Diagnostics Incorporated, Agilent Technologies, Inc.


Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry


Customization Options:

The Non-Invasive Prenatal Testing (NIPT) Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

1.1.Market Definitions
1.4.Currency used in Report
2.1.Research Process of the Non-Invasive Prenatal Testing (NIPT) Market
2.2.Research Methodology of the Non-Invasive Prenatal Testing (NIPT) Market
2.3.Forecasting Method
2.4.Respondent Profile
2.5.Main Objective of the Non-Invasive Prenatal Testing (NIPT) Market Study




 7.1.1.Ultrasound Devices
 7.1.2.Next-Generation Sequencing Systems
 7.1.3.Polymerase Chain Reaction Instruments
 7.2.1.Assay Kits & Reagents
8.1.Ultrasound Detection
8.2.Biochemical Screening Tests
8.3.Cell-Free DNA in Maternal Plasma Tests
9.1.Trisomy Detection
9.2.Microdeletion Detection
10.1.Hospitals & Clinics
10.2.Diagnostic Laboratories
11.1.North America
 11.1.3.Rest of North America
 11.2.5.Rest of Europe
 11.3.5.South Korea
 11.3.6.Rest of Asia-Pacific
11.4.Rest of World
12.1.Market Drivers
12.2.Market Challenges
12.3.Impact Analysis
16.1.Demand Side Analysis
16.2.Supply Side Analysis
 16.2.1.Top Product Launches
 16.2.2.Top Business Partnerships
 16.2.3.Top Business Expansions
 16.2.4.Top Merger and Acquisitions
17.1.Competitive Landscape
 17.1.1.Company Shares, By Revenue
18.1.Illumina, Inc. 
18.2.Yourgene Health
18.4.F. Hoffmann-La Roche Ltd
18.5.PerkinElmer Inc.
18.6.Laboratory Corporation of America
18.7.Eurofins LifeCodexx GmbH
18.8.Centogene N.V.
18.9.Quest Diagnostics Incorporated
18.10.Agilent Technologies, Inc.

Research Methodology

Analyzing the historical market, estimation of the current market, and forecasting the future of the Non-Invasive Prenatal Testing (NIPT) Market were the three major steps undertaken to create and analyze the demand and sales of Non-Invasive Prenatal Testing (NIPT) across major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were conducted, with industry experts across the value chain of the industry. Post assumption and validation of market numbers through primary interviews, we employed a bottom-up approach to forecast the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments the industry pertains to. Detailed methodology is explained below.

Seek More Details About Research Methodology

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detailed secondary study was conducted to obtain the historical market size of the Non-Invasive Prenatal Testing (NIPT) through company internal sources such as annual report & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the Non-Invasive Prenatal Testing (NIPT), we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments included in the report are product, method, application, and end-user. Further regional level analyses were conducted to evaluate the overall demand of Non-Invasive Prenatal Testing (NIPT) in global context.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size. Further, we conducted factor analysis using dependent and independent variables such as like growing demand for Non-Invasive Prenatal Testing (NIPT) products like pan, scented supari, and pan masala. Historical trends and their year-on-year impact on the market size and share was analyzed. Demand and supply side scenario was also thoroughly studied.


Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the Market, and market shares of the segments and company. All the required percentage split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., bottom-up approach was applied to arrive at the market forecast to 2027 for different segments and sub segments across the major regions globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value (US$) and the demand of Non-Invasive Prenatal Testing (NIPT) across the major regions globally
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the Non-Invasive Prenatal Testing (NIPT) Market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market.


Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, Country Head, etc.) across major countries. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Non-Invasive Prenatal Testing (NIPT) Market
Non-Invasive Prenatal Testing (NIPT) Market


Market Engineering

Data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers of each segment and sub-segment of the Non-Invasive Prenatal Testing (NIPT) market. Data was split into several segments & sub-segments post studying various parameters and trends in the areas of product, type, color, and regions.

The main objective of the Non-Invasive Prenatal Testing (NIPT) Market Study

The current & future market trends of the Non-Invasive Prenatal Testing (NIPT) Market are pinpointed in the study. Investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. Current and future market trends would determine the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit as a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of Non-Invasive Prenatal Testing (NIPT) in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments of the industry
  • Segments in the study include product, distribution channel, and regions
  • Defined analysis of the regulatory framework for the Non-Invasive Prenatal Testing (NIPT) industry
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors pertaining to the industry
  • Analyze the current and forecast market size of the Non-Invasive Prenatal Testing (NIPT) across the globe. Major regions analyzed in the report include North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Italy, Rest of Europe); Asia-Pacific (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific); and Rest of World. Define and analyze the competitive landscape of the Non-Invasive Prenatal Testing (NIPT) sector and the growth strategies adopted by the market players to sustain in the fast-growing market

Deep dive regional level analysis of the industry